Canadian Urological Association (CUA)

Management of Medication-Refractory Overactive Bladder (OAB)

Episode Summary

Management of Medication-Refractory Overactive Bladder (OAB)

Episode Notes

Disclosures:

Kevin Carlson
Advisory Board/Payment: Abbvie

Richard Baverstock
Advisory Board: Abbvie
Speakers Bureau: Astellas, Boston Scientific, Abbvie
Payment: Abbvie, Astellas, Bsci

Greg Baily
Advisory Board/ Speaker Bureau: Abbvie